Immunoassay Market Outlook 2025–2029: Emerging Opportunities and Key Drivers
Uncover key drivers, emerging technologies, and competitive movements shaping the immunoassay market from 2025–2034 with trusted insights from The Business Research Company
What Is The Present Size Of The Immunoassay Market And What Value Is Projected For 2029?
The immunoassay market size has shown consistent expansion in recent years. It is anticipated to expand from $35.81 billion in 2024 to $37.32 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.2%. The increase observed in the historic period can be linked to aspects like disease prevalence, an aging population, infectious disease outbreaks, the adoption of point-of-care testing, and increased research funding.
The immunoassay market is anticipated to experience robust expansion over the coming years, with its valuation projected to reach $49.4 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast period is largely due to factors such as personalized medicine, the broadening of emerging markets, enhanced pandemic preparedness, advancements in cancer diagnostics, and the increasing adoption of home-based testing. Key developments expected during this period encompass initiatives for regulatory harmonization, the emergence of multipurpose immunoassays, personalized assay services, the incorporation of wearable technology, and the miniaturization of assay systems.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9838&type=smp
What Factors Are Boosting The Immunoassay Market?
The anticipated expansion of the immunoassay market is linked to the rising prevalence of infectious and chronic diseases in the foreseeable future. Chronic conditions are generally defined as those lasting a year or longer, necessitating ongoing medical attention, limiting daily functions, or a combination of these factors. Infectious diseases, on the other hand, originate from agents like bacteria, viruses, fungi, or parasites; many such organisms naturally reside within or on the human body, and various infectious illnesses can spread between individuals. Immunoassay technology plays a crucial role in identifying a range of both infectious and chronic health issues. For example, a 2023 report from the National Institutes of Health (NIH), a US-based biomedical research agency, projects a significant increase in the United States. It forecasts that the number of individuals aged 50 and older suffering from at least one chronic illness will climb by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Furthermore, the population experiencing multimorbidity is projected to increase by 91.16%, growing from 7.8304 million in 2020 to 14.968 million in 2050. Consequently, the growing incidence of infectious and chronic illnesses serves as a primary driver for the market.
What Are The Core Segmentation Criteria In The Immunoassay Market?
The immunoassaymarket covered in this report is segmented –
1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services
2) By Specimen: Blood, Saliva, Urine, Other Specimens
3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications
4) By End User: Research And Academic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies And CROs, Blood Banks, Hospitals And Clinics, Clinical Laboratories
Subsegments:
1) By Reagents And Kits: ELISA Kits, Rapid Test Kits, Control Reagents, Assay Development Reagents
2) By Analyzers Or Instruments: Automated Analyzers, Point-Of-Care Testing Devices, Microplate Readers, Luminometers
3) By Software And Services: Data Management Software, Analytical Software, Support And Maintenance Services, Consulting Services
Which Emerging Trends Are Reshaping The Immunoassay Market Landscape?
Product innovation represents a significant trend gaining traction in the immunoassay market. Leading companies operating within the immunoassay market are concentrating on developing advanced products to enhance their market standing. For instance, in November 2022, Getein Biotech Inc., a China-based biotechnological company involved in the manufacturing, sales, service, and research and development of in vitro diagnostic reagents and tools, unveiled MAGICL 6000 at MEDICA 2022. The MAGICL 6000 is a portable, cutting-edge chemiluminescence immunoassay analyzer, presented as an optimal choice for laboratories with mid- to high-workflow requirements seeking a one-step chemiluminescence solution. This instrument is notably efficient and compact, facilitates completely automated operation, and possesses the quickest assessment frequency among devices of its size.
Which Players Are Shaping The Competitive Landscape Of The ImmunoassayXX Market?
Major companies operating in the immunoassay market include Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Becton Dickinson and Company, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techn, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGE, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd, Danaher Corporation, Hologic Inc., Tecan Trading AG, Eurofins Scientific, Abcam plc, Enzo Biochem Inc., Luminex Corporation, Quanterix Corporation, Roche Diagnostics, ZEUS Scientific Inc.
Download The Full Report Here:
https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report
What Regional Trends Are Shaping Growth In The Immunoassay Market?
North America was the largest region in the immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunoassay market report during the forecast period. The regions covered in the immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=9838&type=smp
Browse Through More Reports Similar to the Global Immunoassay Market 2025, By The Business Research Company
Neurology Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
Neurodegenerative Disorder Therapeutic Global Market Report 2025
Neurophysiology Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
